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A B S T R A C T
The aim of this retrospective study was to evaluate the demographics and clinical characteristics of patients with pul-
monary embolism treated in medical intensive care unit (ICU) at the University Hospital during a six-year period, and to
assess the impact of several risk factors on patients’ survival. The study included 165 patients, mean age 69.3 ± 13.7
years, predominantly female (70.3%). Dominant symptom was dyspnea (97.0%), the most common sign tachypnea (69.6%).
Pulmonary embolism was confirmed by high-probability ventilation/perfusion lung scan or multidetector computed to-
mography in 71.5% and was regarded as massive in 63 (38.2%), submassive in 23 (13.9%) and non massive in 79 pa-
tients (47.9%). Mean hospital stay was 5.7 ± 4.4 days for ICU, and 14.8 ± 9.1 days, overall. The ICU mortality was 26.7%
and in-hospital mortality 30.9%. No statistical difference in mortality between male and female patients was observed
(30.6% and 31.0%, respectively; p=0.965), but prolonged immobilization (p=0.002), recent operation (p=0.034) or malig-
nancy (p=0.009) were shown to influence the outcome. Although a number of risk factors for developing pulmonary em-
bolism have been identified and heparin prophylaxis along with early mobilization proposed to reduce the incidence, pul-
monary embolism remains an important clinical problem with high mortality rate. The diagnostics should not wait and
the therapy should start as soon as possible.
Key words: pulmonary embolism, epidemiology, ventilation/perfusion lung scintigraphy, multidetector computed to-
mography of lungs, outcome
Introduction
Pulmonary embolism is an acute obstruction of blood
flow to pulmonary circulation usually by a blood clot. It is
a common cardiovascular illness with an incidence of
1–2% in general population1. Althoughmultidetector com-
puted tomography (MDCT) and D-dimer test have revo-
lutionized its diagnostics, the disease still remains unde-
tected in a small number of cases. It is estimated that the
incidence of pulmonary embolism among hospitalized
patients varies between 12 and 20%2. Patients with pul-
monary embolism present with a wide spectrum of ill-
ness that ranges from mild to severe, even death. The
aim of our study was to evaluate the demographic data as
well as clinical characteristics of patients treated for pul-
monary embolism in medical intensive care unit (ICU) at
the University Hospital. Also to assess the impact of sev-
eral risk factors on survival. The findings might be useful
in improving our efforts to timely recognize the disease,
start treatment as soon as we can and work on preven-
tion if possible.
Patients and Methods
This study was a retrospective analysis of all the
charts of patients that were admitted to the ICU of the
Department of Medicine, University Hospital 'Sestre mi-
losrdnice', Zagreb, Croatia, with suspected diagnosis of
acute pulmonary embolism between January 2000 and
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December 2005. Patients were examined in the Emer-
gency Room (ER) and after the pulmonary embolism was
suspected, the ER attending requested admission to the
ICU. The diagnosis of pulmonary embolism was sus-
pected in patients complaining of sudden shortness of
breath – dyspnea, chest pain, dry cough or hemoptysis.
Tachypnea (defined as more than 18 breaths per min-
ute), hypotension (systolic blood pressure (BP) less than
90 mmHg), tachycardia (heart rate (HR) more than 100
beats per minute) or syncope were noted as signs that
strengthened the diagnosis made by the ER physician
even further. Patients were also being examined in the
ER for the signs of right ventricular dysfunction (dis-
tended jugular veins, accentuated pulmonary component
of the second heart tone, or tricuspid regurgitation mur-
mur). To each patient an electrocardiogram (ECG) was
recorded on admission and the chest X-ray performed for
the exclusion of other lung pathology. Abnormal ECG
findings suggestive of pulmonary embolism were recor-
ded as follows: sinus or supraventricular tachycardia,
complete or incomplete right bundle branch block, S1Q3T3
pattern, or inverted T waves in right precordial leads.
Two hundred and fourteen charts from the ER were
coded as pulmonary embolism. The exclusion process
conducted by authors consisted of yet another clinical as-
sessment made by the ICU specialist on the day of admis-
sion, ECG and chest X-ray findings or by high-probabil-
ity ventilation/perfusion (V/Q) lung scan or MDCT (if
available on the day of admission), Figure 1.
Upon admission to the ICU some patients have had
the echocardiography performed, and right ventricular
dysfunction was being diagnosed in the presence of one
of the following criteria: a) right ventricular dilation (di-
astolic diameter >30 mm), b) paradoxical motion of
interventricular septum, c) hypokinesis of the free wall
of the right ventricle, d) tricuspid valve regurgitation (jet
velocity >2.5 m/s), e) pulmonary hypertension. If D-
-dimer test was done (Nyocard D-dimer Single Test,
Axis-Shield PoC AS, Oslo, Norway), the value was re-
corded as well as the Duplex scan sonogram of the lower
extremities that was used to confirm or exclude the pres-
ence of deep vein thrombosis.
Based on BP, clinical presentation and/or echocardio-
graphic examination, patients were finally assessed as
having: 1) non massive pulmonary embolism – in the ab-
sence of systemic hypotension and right ventricular dys-
function, 2) submassive pulmonary embolism – with
right ventricular dysfunction but normal BP and 3) mas-
sive pulmonary embolism – those presenting with hypo-
tension or cardiogenic shock and signs of right ventricu-
lar dysfunction. For final confirmation of the pulmonary
arteries embolization either high-probability ventilation/
perfusion (V/Q) lung scan or MDCT were used. Patients
under the age of 75 years with symptoms of massive pul-
monary embolism admitted within 24 hours and no risk
for major bleeding (contraindications were followed ac-
cording to the Guidelines on diagnosis and management
of acute pulmonary embolism3 from 2000) were treated
with thrombolytics (streptokinase, loading dose: 250,000
IU over 30 minutes, followed by 100,000 IU/h over 24
hours). Others received unfractionated heparin (initial
bolus of 5,000 IU followed by a continuous infusion of
1,000 IU/h – the dosage monitored by aPTT and adjusted
by Raschke nomogram4) and later on warfarin tablets
(Marivarin, Krka, Novo Mesto, Slovenia).
Statistical analysis
For descriptive purposes, all continuous variables were
reported as mean ± standard deviation (SD), or median
and corresponding range for variables with non-Normal
distribution. Qualitative variables were presented as fre-
quency tables, and differences tested using chi-square
(c2) test while variables with inhomogeneous variances
were tested by Kruskal-Wallis test. P values of <0.050
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Excluded by clinical judgment:
– heart failure (n=8)
– pneumonia (n=2)
– paroxysmal atrial fibrillation (n=2)
– cancer (n=3)
Excluded by ventilation/perfusion
lung scintigraphy or multidetector
computed tomography (n=34)
Analyzed
(n=165)
Assessed for
eligibility
(n=214)
Fig. 1. Flow chart of the run-in period.
TABLE 1
CHARACTERISTICS OF 165 PATIENTS WITH PULMONARY
EMBOLISM ADMITTED TO MEDICAL INTENSIVE CARE UNIT IN
THE UNIVERSITY HOSPITAL
Characteristic Number (%) of patients
Sex
Male 49 (29.7)
Female 116 (70.3)
Age (mean ± SD)
Male 66.5 ± 14.5
Female 70.5 ± 13.3
Season
Spring 45 (27.3)
Summer 34 (20.6)
Autumn 50 (30.3)
Winter 36 (21.8)
Admission from
Emergency room 109 (66.1)
Medical ward 23 (13.9)
Another clinic or hospital 33 (20.0)
were considered significant. Statistical analysis was per-
formed with the Statistical Package for Social Sciences,
version 10.0 for Windows Release (SPSS, Chicago, IL,
USA).
Results
Overall, authors went through hospital records of 214
patients admitted to the ICU with suspected diagnosis of
acute pulmonary embolism. After the exclusion process,
165 records (77.1%) remained for final analysis, Figure 1.
Demographic data regarding age, sex and data on hospi-
tal admissions for pulmonary embolism are numbered in
Table 1.
In our patient population dyspnea was the most pro-
minent symptom (97.0%). Tachypnea was present in
69.6% and chest pain in 35.8% (Table 2). Patients were
differently responsive to the symptoms. Fifty-two of them
(31.5%) came to hospital within eight hours of the onset
of symptoms but 58 (35.2%) came after three or more
days though having symptoms. At the time of diagnosis
heart rate was above 100 beats per minute in 52.7% of
patients and systolic BP was below 90 mmHg in 24.2% of
patients (Table 2). Clinical signs of right ventricular
overload according to the aforementioned criteria are
listed in Table 2.
Patients were analyzed according to chronic heart
and lung disease. Fifty-eight percent had hypertension,
28.5% history of congestive heart failure, 11.5% coronary
artery disease and 9% chronic obstructive pulmonary
disease. Fifty two patients had more than one chronic
condition.
To achieve the final diagnosis and confirm the pulmo-
nary embolism several diagnostic tools were used (Table
3). Sinus tachycardia, S1Q3T3 pattern and inversion of
the T wave were the most frequently found signs on ECG
while the most common abnormality found on chest
X-ray were pleural effusion in 13.3%, elevated hemi-
diaphragm in 9.1% and infiltrate in 7.3%. D-dimer test-
ing was done in 147 patients (89.1%), with a mean value
3.60 ± 3.89 mg/L. D-dimer levels were normal in 13,3% of
patients.
Duplex scan sonography of the lower extremities was
performed in 70 patients (42.4%) and 20% had no evident
deep vein thrombosis (Table 4). There was no significant
difference in affection of either the left or right leg. Venti-
lation/perfusion lung scintigraphy was performed in 109
patients (66.1%) and pulmonary embolism found to be
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TABLE 2
CLINICAL PRESENTATION OF PATIENTS WITH PULMONARY
EMBOLISM ON ADMISSION
Signs and symptoms*
Number (%) of
patients (n=165)
Dyspnea 160 (97.0)
Tachypnea (>18 breaths/min) 115 (69.6)
Chest pain 59 (35.8)
Cough 36 (21.8)
Syncope 31 (18.8)
Hemoptysis 4 (2.4)
Hypotension (systolic BP<90 mmHg) 40 (24.2)
Tachycardia (HR>100 beats/min) 87 (52.7)
Clinical signs of RV overload
S3 13 (7.9)
Distended neck veins 25 (15.2)
Accentuated P2 8 (4.8)
Tricuspid regurgitation 16 (9.7)
* Abbreviations: BP – blood pressure, HR – heart rate, RV – right
ventricle, S3 – third heart tone, P2 – pulmonary component of
second heart tone
TABLE 3
DIAGNOSTIC INVESTIGATIONS USED TO DETECT THE LIKELIHOOD OF PULMONARY EMBOLISM
Diagnostic investigation*
Number of patients, n=165
Yes No Percentage obtained mean ± SD†
ECG 165 0 100.0 –
Chest X-ray 162 3 98.2 –
Ventilation – perfusion lung scintigraphy 109 56 66.1 –
MDCT 9 156 5.4 –
D-dimer (mg/L) 147 18 89.1 3.6 ± 3.9
Duplex scan 70 95 42.4 –
* Abbreviations: ECG – electrocardiogram, MDCT – multidetector computed tomography
† when applicable
TABLE 4
DUPLEX SCAN SONOGRAPHY OF VEIN CIRCULATION
ON LOWER EXTREMITIES
Thrombosis Number (%) of patients (n=70)
Lower leg 20 (28.6)
Upper leg 24 (34.3)
Pelvic 12 (17.1)
None 14 (20.0)
highly probable in 88.9% of patients and of medium prob-
ability in 11.1%. Pulmonary embolism was confirmed by
MDCT in only nine patients (5.4%) and solely in 2005
when this method was introduced to our hospital. The
remaining 47 patients (28.5%) were treated for pulmo-
nary embolism and included in the study although the di-
agnosis was not confirmed by the above mentioned tech-
niques but was based on clinical presentation, ECG,
and/or echocardiography and positive D-dimer testing.
In-hospital mortality was 30.9%. A post mortem was
performed on 30 patients (58.8%) and the initial diagno-
sis of pulmonary embolism confirmed in 24 of these pa-
tients. There was no statistical difference in mortality
betweenmale and female patients (30.6%:31.0%), p=0.965.
Reduced mobility, recent operation, history of deep vein
thrombosis or malignoma, on the other hand, were shown
to influence survival, Table 5.
Prolonged bed rest, malignancy and obesity (body
mass index >30 kg/m2), were the most common risk fac-
tors recorded among our patient population (Table 5).
Thirty five women were considered obese as opposed to
only five men (21.2% and 3.0%, respectively, p=0.005).
Twenty percent (33 patients) had no evident predisposi-
tion for developing pulmonary embolism. Post-operative
pulmonary embolism encountered in 21.8% of patients
was seen particularly after abdominal operation or trauma.
Out of 56 patients that were admitted from other medi-
cal wards or another Clinic or hospital, 33 of them
(58.9%) received low molecular weight heparin (LMWH)
prophylaxis.
Based on clinical judgment and echocardiography (if
performed), pulmonary embolism was regarded as mas-
sive in 63 (38.2%), submassive in 23 (13.9%), and non
massive in 79 patients (47.9%). The highest death rate
(64.7%) was in the group with massive pulmonary embo-
lism. Mortality in the two other groups was 19.6% and
15.7%, respectively.
Ninety-two percent of patients received heparin and
only five (3%) were eligible for thrombolytic therapy with
streptokinase. Three patients had minor bleeding as a
complication (hematoma on puncture site). The average
ICU stay of survived patients was 7.1 ± 4.4 days, (median 6,
range 1–26 days). One hundred and ten survivors out of 114
(96.5%) were discharged with oral anticoagulant therapy.
The average weakly dose of warfarin was 23.9 ± 11 mg.
Discussion
To the best of our knowledge, there is no national reg-
istry for pulmonary embolism in Croatia, nor has there
been a study published, that would systematically de-
scribe main epidemiological characteristics of such pa-
tients. Therefore, by collecting data regarding demo-
graphic and clinical characteristics of patients with pul-
monary embolism and analyzing this data we hoped to
gain insights on the effect of certain predisposing factors
on patients survival and our ability to make a timely di-
agnosis, to treat successfully and prevent it when possible.
Our results show that more female patients were hos-
pitalized and treated for pulmonary embolism which is
contrary to some findings already described by both An-
derson et al.5 and Silverstein et al.6. They found a slightly
higher incidence of pulmonary embolism in men than in
women. Our female patients were heavier but in order to
say whether obesity was responsible for higher incidence
of pulmonary embolism in women further studies should
be conducted. Pregnancy or oral contraceptive use/hor-
mone replacement therapy, were of no statistical signifi-
cance in the incidence of this thromboembolic incident.
Another thing we noticed was the statistically significant
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TABLE 5
RISK FACTORS FOR PULMONARY EMBOLISM ACCORDING TO OUTCOME (SURVIVAL)
Risk factor*
Patients number (%)
p†
Total (n=165) Survivors (n=114) Non-survivors (n=51)
Prolonged bed rest 49 (29.7) 25 (21.9) 24 (47.1) 0.002
Malignancy 45 (27.3) 24 (21.1) 21 (41.2) 0.009
Obesity 40 (24.2) 31 (27.2) 9 (17.7) 0.191
Operation (within 1 month) 36 (21.8) 30 (26.3) 6 (11.8) 0.034
History of DVT 30 (18.2) 27 (23.7) 3 (5.9) 0.004
History of PE 11 (6.7) 8 (7.0) 3 (5.9) 0.824
Coagulation disorder 5 (3.0) 5 (4.4) – –
Positive family history 5 (3.0) 5 (4.4) – –
Postpartal PE 2 (1.2) 2 (2.5)‡ – –
OCT or HRT 1 (0.7) 1 (1.3)‡ – –
* Abbreviations: DVT – deep vein thrombosis, PE – pulmonary embolism, OCT – oral contraceptive therapy,
HRT – hormone replacement therapy
† c2 test – p<0.050 is considered statistically significant
‡ n=80 (female survivors)
difference between survivors and non survivors in con-
nection to the risk factors recorded on admission (pro-
longed bed rest, malignancy, an embolic incident follow-
ing surgery or the history of deep vein thrombosis),
which is consistent with findings of White7. The presence
of these risk factors should guide physicians to consider
the possibility of PE before it actually occurs and initiate
thromboprophylaxis. Seasonal variations that were de-
scribed by Boulay et al.8, with a higher incidence of fatal
pulmonary embolism during winter, were not observed
in our patients, probably due to the predisposing factors
already mentioned.
It has been said that to diagnose pulmonary embolism
one has to think of it first. That is why some cases re-
main unrecognized and are found on autopsy only. There
is no doubt that early diagnosis reduces mortality9. Un-
fortunately the clinical presentation is not always typical
as there is no pathognomonic sign that would unequivo-
cally prove the diagnosis. Modern techniques such as
MDCT may certainly help. We used Wells criteria for the
likelihood of PE and if there was a high clinical suspicion
(Wells score >4.0), D-dimer value guided the diagnostic
and therapeutical decision10. The low rate of MDCT con-
firmed pulmonary embolism in our study was mainly due
to the late implementation of this method at our hospital
(in 2005) as well as to contraindications for the use of
radiocontrast or significant renal impairment. The ma-
jority of our patients had a V/Q lung scan performed to
obtain the correct diagnosis. PIOPED I study showed
that high probability V/Q lung scan is a sufficient evi-
dence to treat the patient for PE11. Only in case of
hemodynamic instability or severe respiratory failure the
V/Q lung scan was not performed. Continuous monitor-
ing of these patients and their clinical improvement un-
der therapy supported our judgment of pulmonary embo-
lism and validated the initial treatment. Another finding
that led us to the same conclusion was that one fifth of
post mortem results in patients with pulmonary embo-
lism confirmed in vivo, didn’t show thrombi within the
pulmonary circulation, which may have indicated either
spontaneous or therapeutical resolution of thrombi.
The analysis of hospital records showed a small pro-
portion of patients being clinically assessed for signs of
right ventricular overload. It seems we mainly rely on
technical aids instead of physical exam we have all been
trained to do. Duplex scan sonography which may iden-
tify deep vein thrombosis has been underused, according
to our hospital records, for the past five years. There are
several reasons for this. The procedure was instituted at
our hospital in year 2000 and some time was required to
improve our skills. At present, there are only two special-
ists at our hospital who are able to perform the examina-
tion on both hospitalized and ambulatory patients and
there is only one Duplex scan sonograph. A demand is
huge but our possibilities are limiting. Therefore some-
times, when there is clinical evidence of deep vein throm-
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Suspected pulmonary embolism
based on symptoms and clinical signs
Estimate clinical probability of PE
Lung imaging study present at a hospital
MDCT pulmonary angiography Ventilation/perfusion lung scan
Positive Negative Low/intermediate
probability PE
High probability PE Normal scan
Follow-up for other diagnosisTreat PE
Reassess clinical probability of PE
Treat PE
Treat PE
Follow-up for other diagnosis
Negative
High
Angiography
Intermediate
D-dimer test/Duplex scan
sonogram of lower extremities
Angiography
Negative Positive
Follow-up for other diagnosis
Low
PositiveNegative
Positive
Fig. 2. A proposed algorithm of pulmonary embolism diagnostics in hospitals with or without multidetector computed tomography.
PE – pulmonary embolism, MDCT – multidetector computed tomography.
bosis in the PE settings, duplex scan sonography is omit-
ted from the usual workup.
Although a number of risk factors have been de-
scribed, occasionally the clinician is unable to identify
the underlying cause for pulmonary embolism. Calf vein
thrombosis poses a risk, though a lower one12. Our study
showed that deep vein thrombosis often results in pul-
monary embolism with no regard to the localization in
the lower or upper leg. As seen in the study, only 58.9% of
patients after major surgery (such as hip fracture or hip
replacement), which immobilizes a patient for a longer
period, received heparin prophylaxis. Surgeons’ knowl-
edge and attitude towards the significance of thrombo-
embolic incidents is partially responsible, so one of our
goals is to emphasize the importance of perioperative
thromboprophylaxis and help improve prevention and
recognition of thromboembolic incidents on other wards.
Despite modern methods of diagnosis and treatment
pulmonary embolism continues to have an unacceptably
high mortality13. This may be partly because of the ad-
vanced age as well as co-morbidity in such patients or
high number of malignant diseases in terminal phase. It
is of utmost importance to identify patients at high-risk
for an unfavorable outcome and treat them more aggres-
sively, if appropriate. It is essential to point out the fact
that in Croatia alteplase is not registered medication for
treatment of pulmonary embolism. Following the contra-
indications for the use of thrombolytics strictly and bear-
ing in mind that the population studied was an elderly
one (mean age 69 years), the number of patients eligible
for the thrombolytic therapy was rather small and that
may explain high death rate in massive pulmonary embo-
lism of 64.7%. Though similar rates, 65% (patients in
need of CPR), and 58.3%, were reported by Kasper S. et
al.14 and by Goldhaber et al.13, respectively. The overall
in-hospital mortality of 30.9% does not differ a lot from
the data published so far (21–32%)5,8,15.
Pulmonary embolism is not rare and can be fatal. Un-
derstanding the epidemiology of the disease might help
us improve our care regarding the early diagnosis and de-
ciding on the appropriate treatment for the benefit of our
patients. According to the data of this study we propose a
diagnostic algorithm of PE for hospitals with or without
MDCT availability (Figure 2).
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EPIDEMIOLO[KI POKAZATELJI I DIJAGNOSTI^KI PRISTUP BOLESNIKU S AKUTNOM
PLU]NOM EMBOLIJOM U KLINI^KOJ BOLNICI
S A @ E T A K
Cilj ove retrospektivne studije bio je procijeniti demografske i klini~ke karakteristike bolesnika s plu}nom embo-
lijom lije~enih u internisti~koj jedinici intenzivnog lije~enja (JIL) u Klini~koj bolnici tijekom {estogodi{njeg perioda, s
procjenom zna~aja pojedinih rizi~nih ~imbenika na njihovo pre`ivljenje. U studiju je uklju~eno 165 bolesnika, prosje~ne
dobi 69,3 ± 13,7 godina, 70,3% ispitivane populacije su ~inile `ene. Kao naj~e{}i simptom zabilje`ena je dispneja (97,0%),
a kao naj~e{}i klini~ki znak tahipneja (69,6%). Plu}na je embolija dokazana ventilacijsko-perfuzijskom scintigrafijom
plu}a ili multidetektorskom kompjuteriziranom tomografijom u 71,5% bolesnika, stratificiranih u skupine s masivnom
plu}nom embolijom (63 bolesnika – 38,2%), submasivnom (23 bolesnika – 13,9%) i ne masivnom plu}nom embolijom
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(79 bolesnika – 47,9%). Prosje~no trajanje lije~enja u JIL iznosilo je 5,7 ± 4,4 dana, a ukupno 14,8 ± 9,1 dana. Smrtnost u
JIL iznosila je 26,7%, a cjelokupna bolni~ka smrtnost 30,9%. Nije na|eno statisti~ki zna~ajne razlike u smrtnosti boles-
nika po spolu (30,6%:31,0%, p=0,965), dokazan je statisti~ki zna~ajan utjecaj dugotrajne imobilizacije (p=0,002), ne-
davnog operativnog zahvata (p=0,034) i maligne bolesti (p=0,009) na ishod lije~enja. Iako su definirani razli~iti rizi~ni
~imbenici za nastanak plu}ne embolije, te je uz ranu mobilizaciju bolesnika predlo`ena i profilaksa heparinom u cilju
smanjenja incidencije, ova bolest je i dalje zna~ajan klini~ki i epidemiolo{ki problem s visokom smrtno{}u. Dijagnosti~ki
postupak ne smije odlagati po~etak lije~enja.
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